CENCORA, INC. for CENCORA, INC.
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Extend payment increase under CMS FY 2026 Medicare's Part B physician fee schedule. Protecting Patient Access to Cancer and Complex Therapies Act 2025 (H.R.4299) Reimbursement policies impacting drug shortages Part B drug pricing changes Preventing and Mitigating Generic Drug Shortages CMS FY 2026 Medicares Part B Physician Fee Schedule: Proposed Changes to Bonafide Service Fees
| Lobbyist | Covered position, as disclosed |
|---|---|
| FREDERICK ESSIS New | — |
| COREY AUSTIN MCGEE New | — |
| VIVIENNE STAFFORD MITCHELL | — |
| SHELLY MUI-LIPNIK | — |
| DARRELL ROGERS | — |
Pharmacy PHA
Preventing and Mitigating Generic Drug Shortages Ensuring Seniors Access to Critical Medications Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426)- Impacts to pharmacy Part D drug pricing in Inflation Reduction Act (IRA) Support for Fair Pharmacy Reimbursement
| Lobbyist | Covered position, as disclosed |
|---|---|
| FREDERICK ESSIS New | — |
| COREY AUSTIN MCGEE New | — |
| VIVIENNE STAFFORD MITCHELL | — |
| SHELLY MUI-LIPNIK | — |
| DARRELL ROGERS | — |
Health Issues HCR
Essential Medicines Strategic Stockpile Department of Defense Essential Medicines Strategic Stockpile Prescription Information Modernization Act (H.R.4132/S.2027) Mitigation of Drug Shortages Pharmaceutical supply chain resilience National Defense Authorization Act FY2026 (NDAA) Supply Chain Resiliency Most Favored Nation drug pricing proposals Direct to Consumer proposals CMS Medicare Part B Physician Fee Schedule Rule Break Up Big Medicine Act (S. 3822) CMS FY 2026 Medicares Part B Physician Fee Schedule: Proposed Changes to Bonafide Service Fees Role and value of community specialty physicians and MSOs
| Lobbyist | Covered position, as disclosed |
|---|---|
| FREDERICK ESSIS New | — |
| COREY AUSTIN MCGEE New | — |
| VIVIENNE STAFFORD MITCHELL | — |
| SHELLY MUI-LIPNIK | — |
| DARRELL ROGERS | — |
Taxation/Internal Revenue Code TAX
Global Intangible Low-taxed Income (GILTI) Territorial Economic Recovery Act (H.R. 363) The Medical Manufacturing, Economic Development, and Sustainability (MMEDS) Act (H.R. 3042) Restore Economic Vitality and Investment in the Virgin Islands Act (REVIVE VI Act) (858)
| Lobbyist | Covered position, as disclosed |
|---|---|
| FREDERICK ESSIS New | — |
| COREY AUSTIN MCGEE New | — |
| VIVIENNE STAFFORD MITCHELL | — |
| SHELLY MUI-LIPNIK | — |
| DARRELL ROGERS | — |
Trade (domestic/foreign) TRD
Tariff proposed policies
| Lobbyist | Covered position, as disclosed |
|---|---|
| FREDERICK ESSIS New | — |
| COREY AUSTIN MCGEE New | — |
| VIVIENNE STAFFORD MITCHELL | — |
| SHELLY MUI-LIPNIK | — |
| DARRELL ROGERS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.